The GAL4/UAS gene expression system is a precise means of targeted gene expression employed to study biological phenomena in Drosophila. A modified GAL4/UAS system can be conditionally regulated using a temporal and regional gene expression targeting (TARGET) system that responds to heat shock induction. However heat shock-related temperature shifts sometimes cause unexpected physiological responses that confound behavioral analyses. We describe here the construction of a drug-inducible version of this system that takes advantage of tissue-specific GAL4 driver lines to yield either RU486-activated LexA-progesterone receptor chimeras (LexPR) or b-estradiol-activated LexA-estrogen receptor chimeras (XVE). Upon induction, these chimeras bind to a LexA operator (LexAop) and activate transgene expression. Using GFP expression as a marker for induction in fly brain cells, both approaches are capable of tightly and precisely modulating transgene expression in a temporal and dosage-dependent manner. Additionally, tissue-specific GAL4 drivers resulted in target gene expression that was restricted to those specific tissues. Constitutive expression of the active PKA catalytic subunit using these systems altered the sleep pattern of flies, demonstrating that both systems can regulate transgene expression that precisely mimics regulation that was previously engineered using the GeneSwitch/UAS system. Unlike the limited number of GeneSwitch drivers, this approach allows for the usage of the multitudinous, tissue-specific GAL4 lines for studying temporal gene regulation and tissue-specific gene expression. Together, these new inducible systems provide additional, highly valuable tools available to study gene function in Drosophila.
Introduction
The GAL4/UAS system has been widely used to regulate gene expression for functional studies in Drosophila and has been instrumental in making Drosophila one of the most genetically tractable model organisms. GAL4 gene trap or enhancer trap lines are generated via the random insertion of transposons into the Drosophila genome resulting in the disruption of gene expression [1, 2] . A large number of GAL4 driver lines exist and these have been of great value both in screening for insertional mutations as well as providing a powerful means to control targeted gene expression in specific Drosophila tissues [3] .
The TARGET system combines a temperature-sensitive form of GAL80 (GAL80 ts ) and the GAL4/UAS system, allows for the control of gene expression at a specific time by a change in temperature [4] . The GAL80 ts temperature-sensitive mutant protein that blocks GAL4 activity at 18uC, the permissive temperature, while at 30uC, the restrictive temperature, GAL4 is not repressed since the GAL80 protein is inactive. However, temperature changes can result in unintended physiological effects including alterations in aging or lifespan [5, 6, 7, 8, 9] , circadian rhythm [10, 11, 12, 13, 14] , sleep [15] , reproduction [16, 17] , development [18, 19, 20, 21] , learning and memory [19, 22] , olfactory perception [23] , and can induce mutations [24] . Furthermore, our own study found that some UAS lines have ''leaky'' gene expression at higher temperatures resulting in confounding GAL4 independent phenotypes. Therefore, other strategies for controlling target gene expression at specific times in Drosophila have been developed, including hormone-mediated GAL4 activation approaches that include a chimeric GAL4, GAL4-ER, and GeneSwitch systems [25, 26] . In these systems the addition of exogenous molecules such as diethylstilbestrol (DES) or b-estradiol increases GAL4-ER activity [25] , and mifepristone (RU486) induces the GAL4 activity of GeneSwitch [26] . Both systems transactivate target gene expres-sion via the UAS when transgenic flies consume fly food containing hormones. Although the GeneSwitch system is more common now and GeneSwitch-enhancer trap lines have been developed in recent years [27, 28] , it lacks the rich spatial variety that traditional GAL4 drivers provide.
In other organisms, hormone-induced trans-activation is mediated via LexA-fusion proteins. LexPR is a fusion product of a LexA-binding domain (LexA-BD), a p65 activation domain (AD), and the ligand-binding domain (LBD) of the human progesterone receptor [29] . Similarly, XVE is a product of the fusion of the LexA-BD, VP16 AD, and the LBD of the human estrogen receptor [30] . The regulatory mechanisms employed by these fusion products are similar to the GeneSwitch and GAL4-ER systems in that the inducers RU486 and b-estradiol tightly control the activity of LexPR and XVE, respectively.
Here we introduce both the LexRP/LexAop and XVE/LexAop conditional gene expression systems that are linked to the Gal4/ UAS system in Drosophila as alternative approaches for the conditional control of gene expression (Figure 1 ). The new inducible systems incorporate the large array of existing Gal4 drivers to tissue-specific expression of the transactivators, LexRP/ LexAop and XVE/LexAop, which can be conditionally regulated (turned on and off) by hormone inducers to further regulate transgene expression in flies. We demonstrate that both systems can precisely and tightly regulate a reporter gene expression specifically in a time-and dosage-dependent manner in fly brain cells. In addition using these systems we were able to reproduce the results of previous behavioral studies in which a constitutively active form of the mouse protein kinase A (PKA) catalytic subunit was used to alter sleeping patterns. Since the spatially and temporally precise control of gene expression is crucial to understanding complicated biological functions, our new inducible systems provide an additional experimental approach that will be useful for future Drosophila research.
Results

Identification of attP Sites that Support the Precise Regulation of Transgenes Following a Temperature Shift
The modified GAL4/UAS system (the TARGET system) can be conditionally regulated by a temperature-sensitive allele of GAL80 (GAL80 ts ). At lower, permissive temperatures, GAL80 inhibits gene expression from the UAS promoter whereas, following a temperature shift, GAL80 is inactivated thereby allowing for the induction of GAL4-regulated gene expression. To determine whether shifting temperatures leads to leaky (Gal4-independent expression) transgene expression and to assess which existing attP sites are least susceptible to these effects, the induction of a series of lines containing different attP loci with UAS-luciferase reporter insertions were measured under the same temperature regime as used in the TARGET system.
Basal levels of luciferase activity were detected from the heterozygous UAS-luciferase transgenic lines in the absence of a GAL4 driver (Figure 2A ). Upon temperature shift, a dramatic change in luciferase activity was observed in the UAS-luciferase lines with the attP18, attP33, attP83, and attP154 landing sites ( Figure 2B ), suggesting that these sites may result in leaky expression when used to generate UAS transgenic lines. Interestingly, five UAS-luciferase lines with tightly expressed loci (attP2, attP10, attP14, attP24, and attP40) maintained low levels of luciferase activity following temperature shift when compared to those that were not subjected to the shift, indicating that these constitute the optimal sites for transgene regulation using the TARGET system.
Construction of the Hormone-Inducible LexPR and XVE Trans-activators to Tightly Regulate Transgene Expression in Drosophila Although the attP loci described above provide precise expression upon temperature shifts, random integration is the most common strategy used for transgene generation. Here we report a new approach using LexPR or XVE in linking the GAL4/UAS and LexAop responders to precisely control transgene expression upon hormone induction (Figure 1) . To evaluate the stability and effectiveness of the different trans-activators and to compare these systems, we used confocal imaging to examine GFP expression by different, tissue-specific Gal4 drivers. The membrane mCD8::GFP marker expression is specific to the glomeruli of the antennal lobes when controlled by the Or22a-Gal4, Or47b-Gal4, and Or67a-Gal4 drivers ( Figure 3A1-C1) . Similarly, mCD8::GFP expression is specific to mushroom bodies (MBs) when controlled by the 247-Gal4 driver ( Figure 3D1 ) and in projection neurons when controlled by the GH146-Gal4 driver ( Figure 3E1 ). Similar expression patterns of the reporter were observed when the same Gal4 drivers were used in combination with UAS-LexPR (at the attP40 site) that was induced with 1.5 mM RU486 for 5 days to transactivate LexAop-mCD8::GFP (at the attP2 site) ( Figure 3A3 -E3, A4-C4). Likewise the reporter gene expression pattern was also recapitulated when Gal4 lines were used to activate UAS-XVE (at the attP40 site) in combination with treatment with 30 mg/mL b-estradiol for 5 days ( Figure 3A6 -C6, D5-E5). In contrast, no GFP expression was detected by confocal imaging of the brains of control flies that were not exposed to inducers ( Figure 3A2 -E2, A5-C5 and D4-E4) indicating that LexPR and XVE tightly regulate GFP expression in response to the inducer.
In particular, the LexPR inducible system showed more robust GFP expression in the MBs compared to that of the GeneSwitch system ( Figure 3D3 and 3F2). GFP was quantified by collecting Z series over a height of 8 mm beginning with the first slice of calyx and extending to the sixth slice, which covered part of the ipsilateral calyx of each sample (Figure S1A-C). We found that the GFP intensity of MB-GeneSwitch 12-1 .UAS-mCD8::GFP in MBs was lower than that of the LexPR inducible system (P = 0.006) and 247-Gal4.UAS-mCD8::GFP (P = 0.015) ( Figure S1D ). Together, these results demonstrate that the new hormone-inducible LexPR and XVE trans-activator systems efficiently and tightly regulate transgene expression in Drosophila.
RU486-inducible LexPR Mediates Transgene Expression in a Time-and Dose-Dependent Manner in Drosophila
To evaluate the efficiency of the LexPR inducible system, we studied the kinetics of LexPR induction in Or22a-Gal4 lines with GFP expression in the DM2 glomeruli of the antennal lobes. Flies with the genotype Or22a-Gal4/UAS-LexPR; LexAop-mCD8::GFP/ + were fed media containing either 2% sucrose or 2% sucrose supplemented with RU486 at concentrations ranging from 0.5 to 3 mM for five days. The expression of LexAop-mCD8::GFP increased with increasing RU486 concentration and no GFP expression was detected in the absence of RU486 ( Figure 4A ). The GFP intensity of the DM2 glomeruli was used as a measure of trans-activation and that of individual DM2 glomeruli was analyzed using 3D projections. Following a five-day RU486 induction, the GFP intensity increased in a dose-dependent manner beginning with 0.5 mM RU486 and reaching a plateau at 1.5 mM RU486 (P = 0.0004, no induction vs 0.5 mM; P = 0.005, 0.5 mM vs 1 mM; P = 0.06, 1 mM vs 1.5 mM). No further increase in GFP intensity was detected at higher RU486 concentrations (P = 0.56, 1.5 mM vs 2 mM; P = 0.56, 2 mM vs 3 mM) ( Figure 4D ).
We also observed a time-dependent increase in the GFP signal following prolonged exposure of RU486 ( Figure 4B ), and this time-dependent increase was significant when comparing two days with increasing induction times (P = 0.005, 2 days vs 3 days; P = 0.0001, 3 days vs 4 days; P = 0.0013, 4 days vs 5 days). Six days of induction with 1.5 mM RU486 resulted in saturated GFP expression and no statistically significant increase relative to a fiveday induction (P = 0.17) ( Figure 4E ). These results indicate that LexPR tightly controls transgene expression in Drosophila in a timeand dose-dependent fashion in response to the RU486 inducer. These results also raised the question of whether GFP expression can be turned off upon inducer removal. After switching flies to food without RU486 on day seven, GFP expression is still strong by day twenty-four ( Figure 4C ) suggesting that the activated LexPR has stable and long-lasting activity or that membrane bound GFP is turned slowly after induction.
LexPR and XVE Bridges Employ Different Binary Systems to Express the Constitutively Active PKA Subunit in MBs and Alter Sleep Patterns in Drosophila
A comparison of the three inducible systems (GeneSwitch, LexPR, and XVE) reveals that GFP expression following induction is observed in MBs at the same time ( Figures 3F2,   3D3 , and 3D5). To evaluate whether there are any functional differences in transgene expression among these inducible systems, sleep activity in different lines was measured. It has previously been shown that PKA expression in Drosophila MBs regulates sleep [31] . We used the constitutively active form of the mouse PKA catalytic subunit (mc*) [32] as the transgene to determine if each of the three systems can modulate sleep activity. We observed that PKA-dependent effects were facilitated by UAS-mc* that was induced using the GeneSwitch line (MB-GeneSwitch 12-1 /UASmc*-attP2), by LexAop-mc* that was induced using the 247-Gal4 expressed LexPR (+/UAS-LexPR-attP40; 247-Gal4/LexAop-mc*-attP2), and XVE (+/UAS-XVE-attP40; 247-Gal4/LexAop-mc*-attP2) in MBs.
Sleep maintenance was altered by disruption of PKA homeostasis in MBs with a reduction in total sleep time and average sleep bout length ( Figure 5A-C) . Restricting the expression of the constitutively active form of the mouse PKA catalytic subunit in adult MBs significantly decreased daily sleep ( Fig. 5A-B) , which is consistent with an earlier report that examined a MB-GeneSwitch 12-1 .UAS-mc*-attP2 line with increased PKA activity [31] . Sleep time was significantly reduced in response to RU486 in MBGeneSwitch 12-1 /PKA animals (P,0.0001) and 247-Gal4/LexPR/ PKA animals (P,0.0001), and in response to b-estradiol in 247-Gal4/XVE/PKA animals (P,0.0001) (Fig. 5B) . The percentage of short duration sleep episodes (5-15 min) increased (P,0.0001) and the long-lasting sleep episodes (150-500 min) decreased Figure 1 . Analysis of UAS-Luciferase Lines to Identify Loci with Low Basal Luciferase Activity After Different Temperature Treatments. Luciferase activity was measured in 16 tests of 3 adults each. Activity was normalized to total protein levels and is shown as arbitrary units (a.u.). Each bar represents the mean (n = 16 for each group), and the error bars represent the standard error (6 s.e.). Luciferase activity was measured in heterozygous UAS-luciferase transgenic flies without a Gal4 driver. (A) Gray bars indicate the luciferase activity of 6-day-old flies reared at 18uC. (B) Black bars indicate the luciferase activity of 2-day-old flies reared at 18uC that were exposed to 25uC for 2 days and then to 30uC for 2 days. White bars indicate the luciferase activity of 2-day-old flies reared at 18uC that were exposed to 30uC for 4 days. doi:10.1371/journal.pone.0050855.g001 (2) (A2-E2) ; UAS-LexPR acting as a bridge in the presence of 1.5 mM RU486 (+) for 5 days (A3-E3 are whole-brain images and A4-C4 are focused on 1 antennal lobe); UAS/XVE in the absence of bestradiol (2) (D4-E4 and A5-C5); UAS/XVE in the presence of 30 mg/mL b-estradiol (+) for 5 days (A6-C6 and D5-E5 are whole-brain images and A7-C7 are focused on 1 antennal lobe). All induction methods activated LexAop-mCD8::GFP expression. Genotypes: (A1) Or22a-Gal4.UAS-mCD8::GFPattP2, (A2-4) Or22a-Gal4.UAS-LexPR-attP40; LexAop-mCD8::GFP-attP2, (A5-7) Or22a-Gal4.UAS-XVE-attP40; LexAop-mCD8::GFP-attP2, (B1) Or47b-(P,0.0001) with disrupted PKA homeostasis in MBs ( Figure 5C ). These behaviors were unaffected in control flies that harbored the effectors even when the inducer was present (Figure 5A-C) . However, there were no significant changes in the number of sleep bouts ( Figure 5D ). These data demonstrate that these systems work equally well in this assay, suggesting that this new approach for temporal regulation of transgene expression provides a better alternative and will be of great benefit to Drosophila research.
Gal4.UAS-mCD8::GFP, (B2-4) Or47b-Gal4.UAS-LexPR-attP40; LexAop-mCD8::GFP-attP2, (B4-7) Or47b-Gal4.UAS-LexPR-attP40; LexAop-mCD8::GFPattP2, (C5-7) Or47b-Gal4.UAS-XVE-attP40; LexAop-mCD8::GFP-attP2, (C1) Or67a-Gal4.UAS-mCD8::GFP, (C2-4) Or67a-Gal4.UAS-LexPR-attP40; LexAop-mCD8::GFP-attP2, (C4-7) Or67a-Gal4.UAS-XVE-attP40; LexAop-mCD8::GFP-attP2, (D1) 247-Gal4.UAS-mCD8::GFP-attP2, (D2-3) 247-Gal4.UAS-LexPR-attP40; LexAop-mCD8::GFP-attP2, (D4-5) 247-Gal4.UAS-XVE-attP40; LexAop-mCD8::GFP-attP2, (E1) GH146-Gal4.UASmCD8::GFP-attP2, (E2-3) GH146-Gal4.UAS-LexPR-attP40; LexAop-mCD8::GFP-attP2, (E4-5) GH146-Gal4.UAS-XVE-attP40; LexAop-mCD8::GFP-attP2, (F1-2) MB-GeneSwitch 
Discussion
The TARGET system allows for gene expression at specific times and locations in Drosophila [4, 33] . However, a caveat of this method is that the necessary temperature shift may result in unintended effects on various biological functions. Alternative methods used to modulate transgene expression involve the addition of compounds or hormones rather than temperature shifts and include the tet-on and tet-off [34, 35, 36] , the GAL4-ER, and the GeneSwitch systems [25, 26, 27, 37] . These methods, however, also have some drawbacks. For example in the fly model, the tet-on [38] , tet-off [39] , GAL4-ER [25] , and GeneSwitch [26] techniques are mainly promoter-driven lines that do not display tissue specificity of transgene expression. Some researchers have successfully combined the tet-off (or tet-on) gene expression systems with the Gal4/UAS system for regulating gene expression [39, 40, 41] . However, the tet-off system uses a GAL4 driver to facilitate downstream tTA gene expression of UAS in specific tissues or cells and further controls target gene expression by the tet operator (tetO) upon exposure to doxycycline (Dox). While this modification overcomes the insufficient drivers in the tet-off system, it requires that flies continuously be fed Dox to maintain target gene expression. This treatment is not ideal since Dox is expensive and the long period of feeding may be harmful to the fly. The tet-off system is more effective than the tet-on system for regulating transgene expression [42] due, in part, to the lower transcriptional activity of rtTA compared with that of LexA::V-P16AD and GAL4 [43] . More importantly, Dox has a stronger adverse effect on fly viability relative to RU486 after continuous exposure ( Figure S2 ). Although the combination of Gal4/UAS and tet-off or tet-on allows for the precise expression of target genes, this approach is not optimal.
In this study GAL4 is used to induce either LexPR or XVE which, following induction with either RU486 or b-estradiol, respectively, results in the expression of a target gene downstream of LexAop. The results demonstrate that ingesting food that contained RU486 (or b-estradiol) enabled LexPR (or XVE) activation and trans-activation of the transgene downstream of LexAop in the transgenic flies. GFP was precisely expressed at the correct spatial location, and the fluorescence intensity was similar to the levels of LexPR (or XVE), indicating the precise specificity and high stability of the two new systems in regulating transgene expression in flies. As shown by measurements of the green fluorescence intensity, transgene expression levels can be regulated either by modulating the inducer concentration or the frequency of inducer feeding.
Hormone induction of transgene expression could be used to replace the induction by a change in temperature in the TARGET system to minimize the unexpected effects of temperature on behavior and development in Drosophila. Moreover, it can be used in combination with existing GAL4 drivers to provide ample options for tissue-specific expression. The combination of the new systems and the existing drivers overcomes the problem of insufficient tissue-specific drivers in the GeneSwitch system.
Materials and Methods
Flies
Flies were reared on standard, yeast-based fly food and housed in 12 h light-dark (LD) cycling incubators at 25uC and 50% humidity. The wild-type Canton-S strain was used. 247-Gal4, GH146-Gal4, Or22a-Gal4, Or47b-Gal4, and Or67a-Gal4 lines were purchased from the Bloomington Drosophila Stock Center (BDSC) at Indiana University, and MB-GeneSwitch 12-1 [44] was a gift from Dr. Ronald Davis (The Scripps Research Institute). UASluciferase flies (including insertions: attP2, attP3, attP10, attP14, attP16, attP18, attP24, attP32, attP40, attP83, attP112, attP154) flies were provided by Dr. Norbert Perrimon (Harvard Medical School, HHMI) [45] . UAS-LexPR-attP40, UAS-XVE-attP40, UAS-mCD8::GFP-attP2, LexAop-mCD8::GFP-attP2, UAS-mc*-attP2, and LexAop-mc*-attP2 flies were generated by injecting transgenes into embryos of 2U flies (w 1118 outcrossed 10 times with Canton-S) using a standard protocol for phiC31-mediated specific insertion on chromosome II attP40 landing loci or on chromosome III attP2 landing loci.
Transgene Constructs
To reduce differential or leaky transgene expression resulting from positional effects, we re-generated UAS and LexAop fly lines by adding a gypsy insulator at both ends of the UAS-transgene and LexAop-transgene. We inserted the transgenes with phiC31 recombinase into attP2 or attP40 sites of flies [45] . First, the UAS-expression vector (p[PUAST-AI]) and LexAop-expression vector (pP[LexAop-AI]) with the attB site and gypsy insulators were constructed. Using pP[GreenPelican] as the starting vector, SpeI was used to cut pP [GreenPelican] . After filling in the cut site, the vector was further cut with SphI to remove the eGFP gene. Similarly, BamHI was used to cut the p[PUAST] vector, and after filling in the cut site, the vector was further cut with SphI. The cut UAS 5X sequences included a mini-hsp70TATA promoter, multiple cloning sites, and an SV40 terminator. Ligation of the removed eGFP gene with pP[GreenPelican] was performed to form the pP[UAST-I] vector. Finally, attB from the pUASTattB vector was cut with SpeI and, after fill-in, was cloned into the filled Tth111I site of pP[UAST-I] to form the pP[UAST-AI] vector. The pP[UAST-AI-LexPR] construct was generated using standard molecular cloning procedures. Dr. Sergei Parinov (The National University of Singapore) kindly provided the pDs (Krt8:LPR-LOP:G4) clone containing single AscI and SphI sites for the release of the LexPR gene [29] and filling-in of the resulting blunt ends. This LexPR fragment was cloned into the filled-in NotI site of the pP[UAST-AI] vector to create the pP[UAST-AI-LexPR] transgene. The pP[UAST-AI-XVE] construct was generated by PCR amplification of the full coding region of XVE [30] with primers XVE-F (59-ATGAAAGCGTTAACGGCCAGGCA-39) and XVE-R (59-TCAGACTGTGGCAGGGAAACCCT-39). Dr. Nam-Hai Chua (Rockefeller University) kindly provided the pER8 clone as a template for PCR, and the amplified fragment was cloned into the pGEM-T Easy vector (Promega, Madison, WI). The pGEM-T Easy vector contains a single EcoRI site for the release of the XVE coding region. Following digestion of the XVE (A2) Sleep was monitored in the absence or presence of 30 mg/ml b-estradiol. Genotypes: +/LexAop-XVE; +/UAS-mc* (green line without inducer), +/ LexAop-XVE; +/UAS-mc* (gray line with inducer), +/UAS-XVE; 247-Gal4/LexAop-mCD8::GFP (blue line without inducer) and +/UAS-XVE; 247-Gal4/ LexAop-mCD8::GFP (cyan line with inducer) (n = 32 for each group). After 6 days of induction with (black bars) or without (white bars) a suitable inducer, sleep behaviors were recorded for 2 days: (B) daily total sleep time, (C) sleep bouts in LD binned according to duration, and (D) the number of bouts. Data from each panel were analyzed using Student's t test, and any differences between various concentrations or treatment durations are indicated: n.s. indicates no significant difference; *** indicates p,0. 
Inducing the Transactivation of LexPR and XVE
The transactivation of LexPR (or XVE) was observed via GFP expression of LexAop-mCD8::GFP in flies. The flies were starved for 12 h and then provided with food containing 5% sucrose, 2% agar, and either 1.5 mM RU486 or 30 mM b-estradiol for 6 days. Additionally, we also used GFP expression resulting from different doses of RU486 to confirm the trans-activation of LexPR. The 3-day-old flies (Or22a-Gal4 driver X UAS-LexRP-attP40; LexAopmCD8::GFP-attP2) were reared with food containing RU486 (0, 0.5, 1, 1.5, or 2 mM) for 1-6 days. Fresh food with the same concentration of inducer was provided every 2 days. GFP expression was observed using a confocal microscope after induction.
Heat-Shock Regimen and Luciferase Activity Assay
Several UAS-luciferase lines with confirmed low basal activity [45] were reared at 18uC. They were later exposed to one of three different temperatures so that any apparent leaky expression of luciferase activity due to temperature changes could be detected. After eclosing, the 6-day-old flies were collected and divided into 3 groups. One group was maintained at a fixed temperature of 18uC for 6 days. The second group was maintained at 18uC for 2 days and later at 30uC for 4 days. The third group was maintained at 18uC for 2 days, 25uC for 2 days, and 30uC for 2 more days. Three flies were collected from each treated group, and we used a steady-GloH Luciferase Assay kit (Promega, Madison, WI) to measure luciferase activity. Flies were collected in 1.5-mL microcentrifuge tubes. Glo Lysis buffer (100 mL) (Promega, Madison, WI) was added to each tube, and samples were homogenized using a minibeadbeater-16 (Biospect products, Bartlesville, OK). Samples were then centrifuged at 4uC and 13000 rpm for 15 min. After centrifugation, 20 mL of the supernatant was transferred to a 96-well white wall plate. After adding 20 mL of Luciferase Luciferin Reagent (Promega, Madison, WI), plates were incubated at room temperature in the dark for 10 min. Fluorescence was measured by a luminometer (PerkinElmer TopCount NXT) (Perkin-Elmer Waltham, MA). A portion of each sample was taken for protein concentration analysis using a BCA Protein Assay Kit (Pierce, Rockford, IL) together with a standard for normalization. The protein assay was performed by diluting 25 mL of fly extract lysate 5 times with lysis buffer and transferring it to a 96-well plate. After the addition of BCA working reagent (200 ml), the plates were incubated at 37uC for 30 min. A spectrophotometer was used to measure the absorption at 562 nm.
Bio-imaging and sample preparation
Fly brains were dissected in isotonic phosphate-buffered saline (PBS). Samples were fixed by incubating them in 4% pformaldehyde and microwaving them in an ice bath for 3 min. Samples were then transferred to 0.25% Triton X-100 in 4% pformaldehyde and microwaved for an additional 3 min in an ice bath. Fixed samples were immersed in penetration/blocking (P/B) buffer (2% Triton X-100, 0.02% NaN 3 , and 10% normal goat serum in PBS) and incubated in a vacuum for 10 min. The buffer was replaced with fresh P/B buffer, and the procedure was repeated 3 more times. Samples were then incubated in P/B buffer at room temperature for 2 h. After a brief rinse with PBS, the brains were counterstained with anti-DLG antibody at room temperature overnight. Samples were washed 3 times with wash buffer (2% Triton X-100 and 3% NaCl in PBS) for 20 min. After washing, samples were incubated with secondary antibody (antimouse-IgG conjugate biotin) (Invitrogen) overnight. After incubation, samples were washed 3 times with wash buffer for 10 min. Finally, samples were incubated in a solution containing Alexa Fluor 633 streptavidin (Invitrogen) overnight, washed 3 times with wash buffer for 10 min, mounted in Focusclear TM (CelExplorer LabsH, Taiwan), and examined using a Zeiss LSM 700 confocal microscope equipped with a 406C-Apochromat water immersion objective lens.
Sleep assay
To examine sleep activity, flies were collected 1 day after eclosion and placed in glass bottles in groups of approximately 100 with food containing 1.5 mM RU486 (or 30 mg/ml b-estradiol) for 5 days. After the induction period, flies were acclimated for approximately 24 h at 25uC in 12-h light/12-h dark (LD) conditions. Flies were then transferred to sleep assay tubes containing a suitable inducer and entrained for 1 day. Locomotor activity was recorded for 3 days in LD by using a Drosophila activity monitor (DAM) (TriKinetics, Waltham, MA) [46] . A sleep episode was defined as a 5-min bin of uninterrupted quiescence, as measured by the DAM system. Activity counts were summed across all wake bins and analyzed. We calculated total sleep time, average length of sleep episodes, and the number of sleep episodes.
Supporting Information
Figure S1 Quantification of GFP under the control of constitutive or inducible expression systems in the MB calyx. The image gallery shows confocal Z-series images from posterior to anterior that include 8 mm stacks (merged) with 7 slices in the ipsilateral calyx of (A) RU486-activated MB-GS.UASmCD8::GFP; (B) RU486-activated 247-Gal4.UAS-LexPR; LexAop-mCD8::GFP and (C) 247-Gal4.UAS -mCD8::GFP. (D) Using 3D projections, the green florescence intensity of Z-stack confocal images was analyzed in 3 samples from each group. Each bar represents the mean, and the error bars represent the standard error (6 s.e.). Data from each panel were analyzed using Student's t test, and any differences between various genetic manipulations are indicated: ** indicates p,0.01 and * indicates p,0.05. Scale bar, 20 mm. 
